Vivani Medical, Inc.

As of June 30, 2026, Vivani Medical Inc. carries a market capitalization of 95.67M, placing it among publicly traded companies globally. Its enterprise value stands at 93.88M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Vivani Medical Inc.'s next confirmed earnings release is scheduled for November 18, 2026.

As of June 30, 2026, Vivani Medical Inc. has 89.41M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Vivani Medical Inc. maintains a current ratio of 3.25, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Vivani Medical Inc. posted a negative return on equity (ROE) of -220.40, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -74.60, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 42.00, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Vivani Medical Inc.'s stock has declined approximately 32.07% over the past 52 weeks. The 50-day moving average sits at 1.13, while the 200-day moving average is 1.09.

Over the twelve months ended June 30, 2026, Vivani Medical Inc. generated - - in revenue and converted that into -23.03M in net income, yielding earnings per share of -0.31. EBITDA reached -23.41M, while operating income came in at -23.83M.

As of June 30, 2026, Vivani Medical Inc. holds 17.41M in cash and equivalents against 15.63M in total debt, resulting in a net debt position of -17.41M. Total book value stands at 16.60M, with working capital of 13.11M providing operational flexibility.

Vivani Medical Inc. produced -22.15M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.05M in capital expenditures, free cash flow totaled -23.20M - equivalent to -0.31 per share.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -28.75: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -35.76, meaning Vivani Medical Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Vivani Medical Inc.'s most recent stock split took place on August 19, 2022 with a 3:1 split ratio.

As of June 30, 2026, Vivani Medical Inc. has an Altman Z-Score of -4.27, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.